跳至主要内容
临床试验/NCT05090267
NCT05090267招募中不适用

Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study

University of Florida1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
80
试验地点
1
主要终点
Reduction of dysbiosis from day 1 to day 90

研究概览

简要总结

This project uses a hybrid trial design to evaluate two biomedical interventions targeting the gut-brain axis. One intervention is portable Transcutaneous Vagus Nerve Stimulator, tVNS, that is hypothesized to stimulate the autonomic nervous system, resulting in decreased inflammation and improved cognition. The second intervention is a probiotic supplement intended to replace gut bacteria that are associated with dysbiosis in persons with HIV and alcohol consumption.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Double (Participant, Investigator)

盲法说明

This is a 2x2 design in which subjects will be randomly assigned to one of 4 interventions groups: tVNS and probiotic (n=20); tVNS and placebo (n=20), sham stimulator and probiotic (n=20), and sham stimulator and placebo (n=20). We will use a computer-assisted stratified block randomization with block size of 4 to assign participants to the intervention. Study participants, investigators, staff, and physicians administering the probiotics or placebo will be unaware of specific group assignment. The stratified, blocked randomization and assignment of participants to the 4 intervention groups will be guided and monitored by Data Science Core.

入排标准

年龄范围
35 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 35-70 years
  • •English or Spanish speaking
  • •Alcohol users
  • •Cognitive impairment
  • •Current CD4>350

排除标准

  • •Diagnosed major psychiatric illness
  • •Consumption of over 300 drinks in the past 30 days
  • •Recent opioid use
  • •Lifetime history of medically-assisted alcohol detoxification
  • •Inpatient or intensive treatment for addictive behaviors in the past 12 months
  • •MRI contraindications
  • •Current antibiotic treatment
  • •Current probiotic use
  • •Physical impairment precluding motor response or lying still.

研究组 & 干预措施

Device (including sham)

Active Comparator

Transcutaneous Vagal Nerve Stimulation (tVNS)

干预措施: Transcutaneous Vagal Nerve Stimulation (tVNS) (Device)

Dietary Supplement (e.g., vitamins, minerals)

Experimental

Visbiome probiotic supplement

干预措施: Probiotic Supplement (Dietary Supplement)

结局指标

主要结局

Reduction of dysbiosis from day 1 to day 90

时间窗: Baseline up to 90 days

The gut microbiome will be analyzed through stool samples to measure for changes in biodiversity including an increase in beneficial bacteria.

Improved cognition from day 1 to day 90

时间窗: Baseline up to 90 days

Various indices of cognition will be measured using standard neuropsychological tests and neuroimaging at multiple time points and examined for change within subjects.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验